predictive biomarkers of recurrence may not be useful for de-escalating treatment in dcis
Published 2 years ago • 224 plays • Length 0:57Download video MP4
Download video MP3
Similar videos
-
5:26
improving risk prediction and decision making in dcis patients
-
1:17
future advances in dcis: de-escalation of hormonal therapy
-
1:55
predictive biomarkers in breast cancer
-
2:28
important biomarkers in luminal type breast cancer and dcis
-
0:38
clinical implications for recurrent nonclonal primary dcis
-
21:53
dcis recurrence and radiation
-
14:29
multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
-
40:39
part ii: dcis research: de-escalating the fear of recurrence
-
5:39
ductal carcinoma in situ: anastrozole versus tamoxifen
-
26:25
treatment decision making for dcis - dr. monica morrow
-
10:42
deescalating dcis experts discuss new data from sabcs
-
16:06
extensive dcis and microcalcifications in patients with breast cancer reaching pcr after nac
-
6:51
recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer
-
4:03
what treatment should women with dcis think about?
-
1:14
dr. silverstein discusses radiation therapy as treatment for dcis
-
1:39
chances of dcis recurrence
-
1:59
dr. rakovitch on predicting risk of recurrence for women with dcis
-
35:18
winship grand rounds may 25, 2016: cletus a. arciero, md, facs
-
52:08
emerging strategies in breast cancer care before, during and after surgery